Paper23201628
Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles.
Kim JK and 6 others. Phys Med Biol, 2012. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles. Papers, record 23201628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23201628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colonic Neoplasms | Major topic |
| Metal Nanoparticles | Major topic |
| Proton Therapy | Major topic |
| Animals | |
| Biological Transport | |
| Cell Line, Tumor | |
| Dose-Response Relationship, Radiation | |
| Mice | |
| Mice, Inbred BALB C | |
| Particle Size | |
| Reactive Oxygen Species | |
| Time Factors | |
| Treatment Outcome |
Source PubMed
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794870 | The Impact of Nanoparticles on Proton Therapy: A Review Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794870 | PubMed |
| 42570096 | Range of dose enhancement factor for gold nanoparticles in radiotherapy using Monte Carlo simulations. | Radiat Environ Biophys | 2026 | https://conductscience.org/library/papers/42570096 | PubMed |
| 42482388 | Radiobiology studies of gold nanoparticle-enhanced radiosensitization in proton therapy. | Med Phys | 2026 | https://conductscience.org/library/papers/42482388 | PubMed |
| 41663740 | Resolving the contradiction between simulation and experimental results of using gold nanoparticles in proton therapy. | Sci Rep | 2026 | https://conductscience.org/library/papers/41663740 | PubMed |
| 41042309 | A Monte Carlo study on the impact of a transverse magnetic field on microscopic dose enhancement of nanoparticles in therapeutic proton beams. | Radiat Environ Biophys | 2025 | https://conductscience.org/library/papers/41042309 | PubMed |
| 40956427 | Comment on "Radiosensitization with metallic nanoparticles under MeV proton beams: local dose enhancement" by Mansouri et al. | Radiat Environ Biophys | 2025 | https://conductscience.org/library/papers/40956427 | PubMed |
| 40927152 | Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation. | Indian J Nucl Med | 2025 | https://conductscience.org/library/papers/40927152 | PubMed |
| 40284510 | Polyacrylic Acid-Coated LaB6 Nanoparticles as Efficient Sensitizers for Binary Proton Therapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284510 | PubMed |
| 40050677 | Carbon ion stimulation therapy reverses iron deposits and microglia driven neuroinflammation and induces cognitive improvement in an Alzheimer's disease mouse model. | Sci Rep | 2025 | https://conductscience.org/library/papers/40050677 | PubMed |
| 39997879 | Gold Nanoparticle-Enhanced Production of Reactive Oxygen Species for Radiotherapy and Phototherapy. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/39997879 | PubMed |
| 39594590 | Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization. | Cells | 2024 | https://conductscience.org/library/papers/39594590 | PubMed |
| 39443616 | Significance of the proton energy loss mechanism to gold nanoparticles in proton therapy: a Geant4 simulation. | Sci Rep | 2024 | https://conductscience.org/library/papers/39443616 | PubMed |
| 39273472 | Microdosimetric Simulation of Gold-Nanoparticle-Enhanced Radiotherapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273472 | PubMed |
| 39203014 | Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization. | Molecules | 2024 | https://conductscience.org/library/papers/39203014 | PubMed |
| 37555747 | Prospects of nanoparticle-based radioenhancement for radiotherapy. | Mater Horiz | 2023 | https://conductscience.org/library/papers/37555747 | PubMed |
| 37345658 | Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection. | JCI Insight | 2023 | https://conductscience.org/library/papers/37345658 | PubMed |
| 37251180 | Gold-Nanoparticles-Enhanced Production of Reactive Oxygen Species in Cells at Spread-Out Bragg Peak under Proton Beam Radiation. | ACS Omega | 2023 | https://conductscience.org/library/papers/37251180 | PubMed |
| 36985905 | Recent Advances in Metal-Based NanoEnhancers for Particle Therapy. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/36985905 | PubMed |
| 36546569 | Nanoscopic biodosimetry using plasmid DNA in radiotherapy with metallic nanoparticles. | J Appl Clin Med Phys | 2023 | https://conductscience.org/library/papers/36546569 | PubMed |
| 36014528 | Secondary Electrons in Gold Nanoparticle Clusters and Their Role in Therapeutic Ratio: The Outcome of a Monte Carlo Simulation Study. | Molecules | 2022 | https://conductscience.org/library/papers/36014528 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23201628
GET https://conductscience.org/api/papers/v1/23201628/cited_by?page=2